Gatterer H, Villafuerte FC, Ulrich S, Bhandari SS, Keyes LE, Burtscher M. Altitude illnesses Nat Rev Dis Primers. 2024;10(1):43.
Google Scholar
Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001;345(2):107–14.
Google Scholar
Burtscher M, Hefti U, Hefti JP. High-altitude illnesses: Old stories and new insights into the pathophysiology, treatment and prevention. Sports Med Health Sci. 2021;3(2):59–69.
Google Scholar
Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;325(18):1284–9.
Google Scholar
Swenson ER, Bärtsch P. High-altitude pulmonary edema. Compr Physiol. 2012;2(4):2753–73.
Google Scholar
Mairer K, Wille M, Burtscher M. The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps. High Alt Med Biol. 2010;11(4):343–8.
Google Scholar
Maggiorini M, Buhler B, Walter M, Oelz O. Prevalence of acute mountain sickness in the Swiss Alps. BMJ. 1990;301(6756):853–5.
Google Scholar
Richalet JP, Larmignat P, Poitrine E, Letournel M, Canouï-Poitrine F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med. 2012;185(2):192–8.
Google Scholar
Burtscher J, Swenson ER, Hackett P, Millet GP, Burtscher M. Flying to high-altitude destinations: is the risk of acute mountain sickness greater?. J Travel Med. 2023;30(4):taad011.
Google Scholar
Beidleman BA, Tighiouart H, Schmid CH, Fulco CS, Muza SR. Predictive models of acute mountain sickness after rapid ascent to various altitudes. Med Sci Sports Exerc. 2013;45(4):792–800.
Google Scholar
Beidleman BA, Fulco CS, Cymerman A, Staab JE, Buller MJ, Muza SR. New metric of hypoxic dose predicts altitude acclimatization status following various ascent profiles. Physiol Rep. 2019;7(20): e14263.
Google Scholar
O’Hara R, Serres J, Dodson W, Bruce W, Ordway J, Powell E, et al. The use of dexamethasone in support of high-altitude ground operations and physical performance: review of the literature. J Spec Oper Med. 2014;14(4):53–8.
Google Scholar
Seiler T, Nakas CT, Brill AK, Hefti U, Hilty MP, Perret-Hoigné E, et al. Do cardiopulmonary exercise tests predict summit success and acute mountain sickness? A prospective observational field study at extreme altitude. Br J Sports Med. 2023;57(14):906–13.
Google Scholar
McMorris T, Hale BJ, Barwood M, Costello J, Corbett J. Effect of acute hypoxia on cognition: a systematic review and meta-regression analysis. Neurosci Biobehav Rev. 2017;74(Pt A):225–32.
Google Scholar
Sampson JB, Kobrick JL. The environmental symptoms questionnaire: revisions and new filed data. Aviat Space Environ Med. 1980;51(9 Pt 1):872–7.
Google Scholar
Roach RC, Bärtsch P, Hackett PH, Oelz O. The Lake Louise Acute Mountain Sickness Scoring System. In: Sutton JRHC, Coates G, editors. Hypoxia and Molecular Medicine. Burlington: Queen City Press; 1993. p. 272–4.
Roach RC, Hackett PH, Oelz O, Bärtsch P, Luks AM, MacInnis MJ, et al. The 2018 Lake Louise Acute Mountain Sickness Score. High Alt Med Biol. 2018;19(1):4–6.
Google Scholar
Johnson TS, Rock PB, Fulco CS, Trad LA, Spark RF, Maher JT. Prevention of acute mountain sickness by dexamethasone. N Engl J Med. 1984;310(11):683–6.
Google Scholar
Rock PB, Johnson TS, Larsen RF, Fulco CS, Trad LA, Cymerman A. Dexamethasone as prophylaxis for acute mountain sickness. Effect of dose level Chest. 1989;95(3):568–73.
Google Scholar
Subudhi AW, Dimmen AC, Julian CG, Wilson MJ, Panerai RB, Roach RC. Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia. J Appl Physiol (1985). 2011;110(5):1219–25.
Google Scholar
Maggiorini M, Brunner-La Rocca HP, Peth S, Fischler M, Böhm T, Bernheim A, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med. 2006;145(7):497–506.
Google Scholar
Rock PB, Johnson TS, Cymerman A, Burse RL, Falk LJ, Fulco CS. Effect of dexamethasone on symptoms of acute mountain sickness at Pikes Peak, Colorado (4,300 m). Aviat Space Environ Med. 1987;58(7):668–72.
Google Scholar
Singh I, Khanna PK, Srivastava MC, Lal M, Roy SB, Subramanyam CS. Acute mountain sickness. N Engl J Med. 1969;280(4):175–84.
Google Scholar
Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 1976;2(7996):1149–55.
Google Scholar
Ellsworth AJ, Larson EB, Strickland D. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am J Med. 1987;83(6):1024–30.
Google Scholar
Hackett PH, Roach RC, Wood RA, Foutch RG, Meehan RT, Rennie D, et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med. 1988;59(10):950–4.
Google Scholar
Zell SC, Goodman PH. Acetazolamide and dexamethasone in the prevention of acute mountain sickness. West J Med. 1988;148(5):541–5.
Google Scholar
Ellsworth AJ, Meyer EF, Larson EB. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. West J Med. 1991;154(3):289–93.
Google Scholar
Bernhard WN, Schalick LM, Gittelsohn A. Dexamethasone for prophylaxis against acute mountain sickness during rapid ascent to 5334 m. J Wilderness Med. 1994;5(3):331–8.
Hussain MM, Aslam M, Khan Z. Acute mountain sickness score and hypoxemia. J Pak Med Assoc. 2001;51(5):173–9.
Google Scholar
Zheng CR, Chen GZ, Yu J, Qin J, Song P, Bian SZ, et al. Inhaled budesonide and oral dexamethasone prevent acute mountain sickness. Am J Med. 2014;127(10):1001-9.e2.
Google Scholar
Chanana N, Palmo T, Sharma K, Kumar R, Shah B, Mahajan S, et al. Sexual dimorphism of dexamethasone as a prophylactic treatment in pathologies associated with acute hypobaric hypoxia exposure. Front Pharmacol. 2022;13: 873867.
Google Scholar
Fischler M, Maggiorini M, Dorschner L, Debrunner J, Bernheim A, Kiencke S, et al. Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema. Am J Respir Crit Care Med. 2009;180(4):346–52.
Google Scholar
Siebenmann C, Bloch KE, Lundby C, Nussbamer-Ochsner Y, Schoeb M, Maggiorini M. Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m. High Alt Med Biol. 2011;12(2):169–77.
Google Scholar
Spoorenberg SM, Deneer VH, Grutters JC, Pulles AE, Voorn GP, Rijkers GT, et al. Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. Br J Clin Pharmacol. 2014;78(1):78–83.
Google Scholar
ADVANZPharma. SmPC Dexamethasone 4 mg tablets. https://www.medicinesorguk/emc/product/10720/smpc#gref. 2024. Accessed 10 May 2024.
Lim W, Park C, Shim MK, Lee YH, Lee YM, Lee Y. Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1α expression through the induction of glucocorticoid-induced leucine zipper. Br J Pharmacol. 2014;171(3):735–45.
Google Scholar
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53.
Google Scholar
Huo Y, Rangarajan P, Ling E-A, Dheen ST. Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neurosci. 2011;12(1):49.
Google Scholar
Barnes PJ. How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol. 2006;148(3):245–54.
Google Scholar
Johnson TS, Rock PB, Young JB, Fulco CS, Trad LA. Hemodynamic and sympathoadrenal responses to altitude in humans: effect of dexamethasone. Aviat Space Environ Med. 1988;59(3):208–12.
Google Scholar
De Oliveira GS, Castro-Alves LJ, Ahmad S, Kendall MC, McCarthy RJ. Dexamethasone to prevent postoperative nausea and vomiting: an updated meta-analysis of randomized controlled trials. Anesth Analg. 2013;116(1):58–74.
Google Scholar
Kenna HA, Poon AW, de los Angeles CP, Koran LM. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci. 2011;65(6):549–60.
Severinghaus JW. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. J Appl Physiol (1985). 1995;79(2):375–9.
Google Scholar
Long JB, Holaday JW. Blood-brain barrier: endogenous modulation by adrenal-cortical function. Science. 1985;227(4694):1580–3.
Google Scholar
Montgomery AB, Luce JM, Michael P, Mills J. Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes. JAMA. 1989;261(5):734–6.
Google Scholar
Sartori C, Duplain H, Lepori M, Egli M, Maggiorini M, Nicod P, et al. High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects. Eur Respir J. 2004;23(6):916–20.
Google Scholar
Marquet P, Lac G, Chassain AP, Habrioux G, Galen FX. Dexamethasone in resting and exercising men. I. Effects on bioenergetics, minerals, and related hormones. J Appl Physiol (1985). 1999;87(1):175–82.
Google Scholar
Jobe JB, Shukitt-Hale B, Banderet LE, Rock PB. Effects of dexamethasone and high terrestrial altitude on cognitive performance and affect. Aviat Space Environ Med. 1991;62(8):727–32.
Google Scholar
Lafleur J, Giron M, Demarco M, Kennedy R, BeLue R, Shields C. Cognitive effects of dexamethasone at high altitude. Wilderness Environ Med. 2003;14(1):20–3.
Google Scholar
Richards RN. Side effects of short-term oral corticosteroids. J Cutan Med Surg. 2008;12(2):77–81.
Google Scholar
Levine BD, Yoshimura K, Kobayashi T, Fukushima M, Shibamoto T, Ueda G. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med. 1989;321(25):1707–13.
Google Scholar
Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–7.
Google Scholar
Liu B, Yuan M, Yang M, Zhu H, Zhang W. The Effect of high-altitude hypoxia on neuropsychiatric functions. High Alt Med Biol. 2024;25(1):26–41.
Google Scholar
Roach RC, Maes D, Sandoval D, Robergs RA, Icenogle M, Hinghofer-Szalkay H, et al. Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol (1985). 2000;88(2):581–5.
Google Scholar
Mairer K, Wille M, Bucher T, Burtscher M. Prevalence of acute mountain sickness in the Eastern Alps. High Alt Med Biol. 2009;10(3):239–45.
Google Scholar
Schoene RB, Roach RC, Hackett PH, Harrison G, Mills WJ. High altitude pulmonary edema and exercise at 4400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest. 1985;87:330–3.
Google Scholar
Luks AM, Swenson ER, Bartsch P. Acute high-altitude sickness. Eur Respir Rev. 2017;26(143): 160096.
Google Scholar
Luks AM, Beidleman BA, Freer L, Grissom CK, Keyes LE, McIntosh SE, et al. Wilderness medical society clinical practice guidelines for the prevention, diagnosis, and treatment of acute altitude illness: 2024 update. Wilderness Environ Med. 2024;35(1_suppl):2s–19s.
Google Scholar